⌘K
t
Haleon plc announced on 02 October 2025 that Tracy Clarke, a Non-Executive Director of Haleon plc, will be appointed as a Non-Executive Director to the Board of Inchcape plc. This appointment is effective 31 December 2025 and was declared in accordance with paragraph 6.4.9R(2) of the UK Listing Rules.
| Date | 2 Oct 2025 |
| Time | 10:05:00 |
| Category | Miscellaneous |
| ID | 8217B |
Haleon plc: Director Declaration
02 October 2025: In accordance with paragraph 6.4.9R(2) of the UK Listing Rules, Haleon plc (LSE/NYSE: HLN) announces that Tracy Clarke, Non-Executive Director, will be appointed to the Board of Inchcape plc (LSE: INCH) as a Non-Executive Director effective 31 December 2025.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.